News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Shah Sujal
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/27/2023 |
4
| Shah Sujal (CEO) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 800,000 options to buy
@ $7.8, valued at
$6.2M
|
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2022 |
4
| Shah Sujal (CEO) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 650,000 options to buy
@ $2.94, valued at
$1.9M
|
|
| 01/28/2021 |
4
| Shah Sujal (CEO) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 287,000 options to buy
@ $5.78, valued at
$1.7M
|
|
| 05/19/2020 |
4
| Shah Sujal (President & CEO) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 558,108 options to buy
@ $4.05, valued at
$2.3M
|
|
| 10/15/2019 |
4
| Shah Sujal (CEO) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $4.3, valued at
$21.5k
|
|
| 09/24/2019 |
4
| Shah Sujal (CEO) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Bought 1,900 shares
@ $5.5, valued at
$10.5k
Bought 3,100 shares
@ $5.55, valued at
$17.2k
|
|
| 01/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2018 |
4
| Shah Sujal (CEO) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $6.5399, valued at
$65.4k
|
|
| 10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2018 |
4
| Shah Sujal (CEO) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $10.9, valued at
$54.5k
|
|
| 05/15/2018 |
4
| Shah Sujal (CEO) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $10.65, valued at
$53.3k
|
|
| 01/26/2018 |
4
| Shah Sujal (CEO) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $11.69, valued at
$1.8M
|
|
| 10/31/2017 |
4
| Shah Sujal (President & CEO) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 640,000 options to buy
@ $9.21, valued at
$5.9M
|
|
| 07/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/06/2016 |
4
| Shah Sujal (CFO) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Bought 22,000 shares
@ $1.39, valued at
$30.6k
Bought 33,000 shares
@ $1.39, valued at
$45.9k
|
|
|
|